Group 3 ILD Associated Pulmonary Hypertension: From the Bench to the BedsideOnline Course Enroll |
Updates on FDA-Approved Therapies for Pulmonary HypertensionOnline Course Enroll |
The New Normal: Impact of the New Hemodynamic Criteria on the Diagnosis and Treatment of PHOnline Course Enroll |
Group 2 PH: Ipc-PH vs Cpc-PHOnline Course Enroll |
Assessment 101: Differentiating PAH from other forms of PHOnline Course Enroll |
Pulmonary Hypertension in Patients With Connective Tissue DiseaseOnline Course Enroll |